Content by Keyword: Prescription Drugs

  • print
  • email
  • twitter
  • compact
PDF report
Public Listing Status of Data-Waivered Providers

Public Listing Status of Data-Waivered Providers: Data Brief

A large proportion of DATA-waivered providers choose not to be publicly listed on the SAMHSA website. Greater proportions of physician assistants and nurse practitioners, compared to physicians, opt to be listed on the SAMHSA website.
  • DWPlisting.pdf
    export-csvPDF
Basic report
Public Listing Status of Data-Waivered Providers

Public Listing Status of Data-Waivered Providers: Data Brief

Mir M. Ali, Robin Ghertner, Laurel Fuller, and Joel Dubenitz U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation Printer Friendly Version in PDF Format (3 PDF pages)
Basic report
State Policy Levers for Expanding Family-Centered

State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment

Julie Seibert, PhD, Holly Stockdale, MA, Rose Feinberg, MA, Erin Dobbins, MA, Elysha Theis, BA, and Sarita L. Karon, PhD RTI International Printer Friendly Version in PDF Format (55 PDF pages)
PDF report
State Policy Levers for Expanding Family-Centered

State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment

Many women facing opioid addiction are either pregnant or caring for children and face a number of social, structural and economic barrier in accessing treatment. In recent years, clinicians and policymakers have become increasingly interested in supporting substance use treatment approaches that provide comprehensive services to pregnant and pare
  • ExpandFCMAT.pdf
    export-csvPDF
Basic report
Expanding Access to Family-Centered Medication-

Expanding Access to Family-Centered Medication-Assisted Treatment Issue Brief

Printer Friendly Version in PDF Format (5 PDF pages) ABSTRACT This Issue Brief represents the finding of a white paper prepared by RTI under funding from ASPE. The analysis included a programs scan of policy initiatives in 21 states and individual interviews with academics, federal experts, state officials and individual providers.
PDF report
Expanding Access to Family-Centered Medication-

Expanding Access to Family-Centered Medication-Assisted Treatment Issue Brief

This Issue Brief represents the finding of a white paper prepared by RTI under funding from ASPE. The analysis included a programs scan of policy initiatives in 21 states and individual interviews with academics, federal experts, state officials and individual providers.
  • FCMATib.pdf
    export-csvPDF
PDF report
Data point: Prescription Pharmaceutical Price

Data point: Prescription Pharmaceutical Price Changes since the Release of the President’s Drug Pricing Blueprint

Using manufacturer-reported prescription pharmaceutical prices, we observe that the number of price increases has been reduced considerably since the release of the President’s Drug Pricing Blueprint, compared to the same time period in the year prior. Since the Blueprint’s release, there are 60% fewer brand name product price increases in 201
  • DPrxpricechanges100dayspostblueprint.pdf
    export-csvPDF
Form Approved OMB# 0990-0379 Exp. Date 9/30/2020